Trials / Conditions / Hyperparathyroidism, Primary

Hyperparathyroidism, Primary

18 registered clinical trials studyying Hyperparathyroidism, Primary — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism NCT06562881	University of Pennsylvania	N/A
Not Yet Recruiting	Parathyroid Adenoma Detection With Rubidium-82 Imaging NCT07099404	Matthieu Pelletier-Galarneau, MD MSc	—
Not Yet Recruiting	WHITE CAP: Intra-operative Parathyroid Tissue Sensor (PTS)-Guided Assessment of Parathyroid Viability and Surg NCT07043010	Fujian Medical University	N/A
Recruiting	Autofluorescence in Surgery for Primary Hyperparathyroidism NCT06230380	Aarhus University Hospital	N/A
Not Yet Recruiting	The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism NCT05556499	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio	—
Completed	Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy NCT05152927	University of California, San Francisco	N/A
Terminated	Primary Hyperparathyroidism and Gut Microbiota NCT04948671	Centre Hospitalier Universitaire Vaudois	—
Recruiting	18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas NCT04895631	Thomas Hope	Phase 3
Completed	Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment NCT05347082	Hospital Regional 1o de Octubre	N/A
Unknown	Study on the Use of Cinacalcet in Phosphocalcic Context. NCT04126954	Hospices Civils de Lyon	—
Completed	FCH PET/MRI Parathyroid Localization NCT03324893	University Health Network, Toronto	N/A
Completed	Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism. NCT03091140	Aristotle University Of Thessaloniki	—
Completed	18F-Fluorocholine for the Detection of Parathyroid Adenomas NCT03764007	Thomas Hope	Phase 2 / Phase 3
Completed	Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparat NCT00975221	Amgen	Phase 3
Completed	PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Pri NCT00928408	Amgen	—
Completed	Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism NCT02417389	Istituto Auxologico Italiano	Phase 4
Completed	A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic NCT00936988	Amgen	Phase 2
Completed	A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 ( NCT00936650	Amgen	Phase 2